ESPN Analyst, tennis legend Chris Evert shares stage 1C ovarian cancer diagnosis
ESPN tennis analyst Chris Evert introduced Thursday that she has been identified with stage 1C ovarian cancer.
In an open letter launched Thursday, Evert mentioned she obtained a textual content—one which was “quick, easy and but so d—” difficult—on Dec. 7 saying that her pathology report indicated she had a malignant tumor in her Fallopian tube.
“I learn the textual content 5 instances,” Evert mentioned within the letter.
The cancer, whereas in an early stage, was found after a preventive hysterectomy. Evert started her first of six rounds of chemotherapy this week.
Seventy to 80% of ovarian cancer is identified at stage 3 or 4, in accordance with Dr. Joel Cardenas of the Gynecology and Oncology Division at Cleveland Clinic Florida close to Fort Lauderdale.
Had Evert not discovered concerning the tumor, she would have been in stage 3 or stage 4 in three months because the cancer would have unfold to her stomach in accordance with Cardenas.
Whereas the early stage of ovarian cancer could be almost not possible to detect, Evert mentioned she felt fortunate to have discovered early.
“As somebody who has at all times had management over my life, I do not know how I will reply to chemotherapy,” Evert mentioned. “I’ve to offer in to one thing greater.”
Whereas coping with her personal diagnosis, Evert has additionally mirrored on the lifetime of her youthful sister—former skilled tennis star Jeanne Evert Dubin—who died from a late stage of ovarian cancer in February 2020. Evert additionally delivered the eulogy at Dubin’s funeral.
“She fought and fought until the bitter finish” Evert mentioned. “For these of us who had been on this journey along with her, it was heartbreaking to observe.”
It was throughout Dubin’s encounter with cancer that Evert underwent the genetic testing to detect early indicators or potentialities of cancer. In accordance with the letter, the genetic info that Dubin left behind probably saved Evert’s life.
Extra Tennis Protection:
